JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ayalew, A.
Right arrow Articles by Bertrand, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ayalew, A.
Right arrow Articles by Bertrand, A.
Journal of Nuclear Medicine Vol. 43 No. 4 566-574
© 2002 by Society of Nuclear Medicine


Basic Science Investigations

201Tl and 99mTc-MIBI Retention in an Isolated Heart Model of Low-Flow Ischemia and Stunning: Evidence of Negligible Impact of Myocyte Metabolism on Tracer Kinetics

Adey Ayalew, MSc1, Pierre-Yves Marie, MD1, Patrick Menu, PhD2, Paul-Michel Mertes, MD3, Sandra Audonnet, MSc1, Valérie Jouan, MSc2, Pierre Olivier, MD1, Gilles Karcher, MD1, Dan Ungureanu-Longrois, MD4 and Alain Bertrand, MD1

1 Department of Nuclear Medicine, UPRES EA 2403, CHU-Nancy, France
2 Laboratory of Hematology and Physiology, Faculty of Pharmacy, University Henri Poincaré, Nancy, France
3 Department of Cardiology, UPRES EA 2403, CHU-Nancy, France
4 Department of Anesthesia, UPRES EA 2403, CHU-Nancy, France

It is not known whether cellular metabolic disorders play a role in the decreased tracer uptake that is documented by conventional SPECT during low-flow ischemia or stunning. This study sought to determine the impact of low-flow ischemia and stunning on the kinetics of 201Tl and MIBI across the plasma membrane of myocytes. Methods: The global myocardial retention (Rf) of 201Tl and MIBI was determined in isolated working hearts from rabbits, perfused with red blood cell–enhanced solution. Experiments were performed in normoxia, with physiological values of coronary flow (N; n = 16); in low-flow ischemia, with a >50% reduction of coronary flow and a >= 20-mm Hg fall in systolic left ventricle pressure (L; n = 15); and in stunning, with 15 min of acute ischemia followed by reperfusion (S; n = 15). Concentration ratios across the plasma membrane of myocytes were also determined for both tracers and expressed as Ci/Cc, where Ci is interstitial activity determined with microdialysis, and Cc is activity from cellular space determined from Rf and Ci values. Results: There was a slight increase in average values of Ci/Cc in ischemia, but not in stunning, for 201Tl (L, 0.011 ± 0.006 vs. N, 0.006 ± 0.004 [P < 0.05]; S, 0.007 ± 0.004 vs. N [not significant]) and for MIBI (L, 0.011 ± 0.008 vs. N, 0.005 ± 0.004 [P < 0.05]; S, 0.005 ± 0.003 vs. N [not significant]). Moreover, ischemia and stunning had no deleterious effects on the average values of global myocardial retention for 201Tl (L, 0.63 ± 0.09 vs. N, 0.50 ± 0.14 [P < 0.05]; S, 0.59 ± 0.10 vs. N [P < 0.05]) or for MIBI (L, 0.45 ± 0.10 vs. N, 0.31 ± 0.09 [P < 0.05]; S, 0.41 ± 0.12 vs. N [P < 0.05]). In fact, these values were significantly enhanced in the 2 situations. Conclusion: The kinetics of 201Tl and MIBI across the plasma membrane of myocytes were affected only poorly by low-flow ischemia and not at all by stunning, without any deleterious effects on myocardial retention of both tracers. During low-flow ischemia or stunning, therefore, the information provided by 201Tl or MIBI SPECT is expected to depend on myocardial perfusion but not on cellular metabolic disorders.

Key Words: 201Tl • 99mTc-MIBI • myocardial ischemia • interstitium • microdialysis




This article has been cited by other articles:


Home page
J. Nucl. Med. Technol.Home page
S. S. Husain
Myocardial Perfusion Imaging Protocols: Is There an Ideal Protocol?
J. Nucl. Med. Technol., March 1, 2007; 35(1): 3 - 9.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.